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I read the manuscript HIV infection en route to endogenization:
two cases [1] with great interest. The authors described two
individuals infected with HIV-1, but without virus expression.
The immune responses indicated that a productive infection
occurred previously, but the proviruses were inactivated by
mutations and the authors proposed that HIV cure may occur
through HIV endogenization [1].
I was, however, surprised to read how the terms ‘endogeni-
zation’ and ‘neutralization’, two well-deﬁned terms in retro-
virology and immunology, were used. First, in retrovirology,
endogenization of a retrovirus is deﬁned as infection of germ cells
(themale sperm cell or the female oocyte) or their precursor cells
with an exogenous retrovirus. As retroviruses integrate a DNA
copy of their RNA genome into the genome of the target cell,
eventually all cells of the organism resulting from the fusion of the
infected germ cells carry this provirus, which is then termed an
endogenous retrovirus. In the publication by Colson et al. [1],
human immunodeﬁciency virus 1 (HIV-1) is not endogenized as
stated repeatedly in their publication, but merely integrated in
only some of the body cells (<20 copies/106 peripheral blood
mononuclear cells), as is typical for all exogenous retroviruses.
Second, although one can of course neutralize an acid, one can
also neutralize a virus to make it inactive, but in immunology
‘neutralization’ generally refers to the antibody-mediated pre-
vention of virus infection. Interestingly, both case patients
described have antibodies neutralizing the HIV-1 strain NL4.3.
I was also surprised at the use of the term ‘cure’: this should
have been termed ‘spontaneous cure’ in contrast to a cure
based on treatment, e.g. with drugs.inical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectLast but not least, the spontaneous cure described was
obviously due to an inactivation of HIV-1 by mutations in
different regions of the viral genome. In one case vif, vpr, vpu
and tat were mostly affected, in the other gag, pol, env and nef.
The authors suppose a role for the cellular restriction factor
APOBEC3G, an RNA editing enzyme exchanging G for A in
viral nucleic acids. Usually, the viral infectivity factor (Vif) pro-
tein of HIV-1 counteracts this effect. Vif interacts with APO-
BEC3G and triggers the ubiquitination and degradation of
APOBEC3G via the proteasomal pathway. Obviously, in one
patient, vif was deactivated by mutations.
The manuscript reports a very interesting mechanism of
virus inactivation and certainly we can learn from this for
further treatment. However, it has nothing to do with endo-
genization and the phenomenon should be called what it is:
inactivation of the provirus in infected cells.
In addition, I would like to draw your attention to the fact
that endogenization of a retrovirus does not automatically
mean inactivation or enslavement for placental development
[2]. Endogenous retroviruses of mice, cats and obviously also
koala are still able to contribute to tumour development and
immunosuppression. Endogenous retroviruses of the pig can be
released as virus particles able to infect human cells. These
represent a potential risk for the use of pig cells or organs in
xenotransplantation. Until now, no replication-competent hu-
man endogenous retroviruses have been found, and their
inactivation reﬂects a long path of evolution. Nevertheless, at
the moment it cannot be excluded that single proteins or
insertional mutagenesis of human endogenous retroviruses
contribute to tumour development in humans [2].
Please allow a ﬁnal short sentence concerning the accompa-
nying editorial [3]. Modesty forbids us to accept that my labo-
ratory demonstrated endogenization of the koala retrovirus [4],
this work was done solely by the laboratory of Paul Young [5].
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